Alpa Laboratories Limited

NSE:ALPA.NS

$101.9 INR

$4 (4.09%)

Volume
17.34K
Average Volume
195.16K
Market Capitalization
$2.14B
P/E Ratio
11.96
Dividend Yield
0.00%
Price Target
$
Year High
$115.00
Year Low
$50.30
Payout Ratio
$0.00
Current Ratio
$0.00

Industry, Sector & symbol

Stock Exchange National Stock Exchange of India
CEO Mr. Mahendra Singh Chawla
Industry Drug Manufacturers—Specialty & Generic
Sector Healthcare
Current Symbol ALPA.NS
CUSIP Y00937105
CIK None
Web https://www.alpalabs.in
Phone 91 73 1429 4567
Currency INR
Employees 318
Country IN

Liquidity

Debt-to-Equity Ratio 0.00
Payout Ratio 0.00
Current Ratio 0.00
Quick Ratio 0.00
Cash Ratio 0.00

Sales & Book Value

Annual Sales $924.36M
Price / Sales 1.88
Cash Flow 1.86
Price / Cash Flow 54.70
Price / Book 0.00

Price Target and Rating

Average Stock Price Forecast $
High Stock Price Forecast $
Low Stock Price Forecast $
Forecast Upside/Downside %
Consensus Rating Buy
Rating Score(0-5) 4
Research Coverage 0 Analysts

Profitability

EPS (Most Recent Fiscal Year) $5.98
Trailing P/E Ratio 11.96
PEG Ratio 2.09
P/E Growth 2.09
Net Income $125.83M
Net Margin 15.69%
Pretax Margin 19.32%
Return on Equity 17.39%
Return on Assets 0.00%

Financials Score

AltmanZ Score
Piotroski Score 5.00
Working Capital -
Total Assets -
Ebit 186.01M
Market Cap 2.06B
Total Liabilities -

Poll Results

About Alpa Laboratories Limited (NSE:ALPA.NS) Stock

Alpa Laboratories Limited engages in manufacturing, marketing, and selling pharmaceutical finished dosage forms in India. It offers ethical, generic, and over the counter products in various finished dosage forms, including injections, tablets, capsules, eye and ear drops, ointments, creams, and gels for human use; and boluses, injections, and intra-mammary infusions for veterinary use. The company also provides drugs in various categories, such as anti-infectives comprising antibacterial, antibiotics, antifungals, antiprotozoals, and antivirals; analgesics; anti-inflammatory drugs; cough and cold drugs; cardiovascular drugs; anti-diabetics; nutritional supplements; psychotropic drugs; and skin care preparations, as well as ear and eye care preparations. It sells its products through distr ... ibutors, retail chemists, retail pharmacy stores, and hospitals. The company also exports its products to South and Central America, Africa, and Asia, and CIS countries. Alpa Laboratories Limited was founded in 1967 and is based in Indore, India.

Frequently Asked Questions

What is the current Alpa Laboratories Limited (ALPA.NS) stock price?

Alpa Laboratories Limited(NSE:ALPA.NS) stock price is $101.9 in the last trading session. During the trading session, ALPA.NS stock reached the peak price of $115.0 while $50.3 was the lowest point it dropped to. The percentage change in ALPA.NS stock occurred in the recent session was 4.09% while the dollar amount for the price change in ALPA.NS stock was $4.

ALPA.NS's industry and sector of operation?

The NSE listed ALPA.NS is part of Drug Manufacturers—Specialty & Generic industry that operates in the broader Healthcare sector.

Who are the executives of ALPA.NS?

Mr. Bakulesh Chandulal Shah | Chief Financial Officer
Mr. Mahendra Singh Chawla | Chairman of the Board
Ms. Swati Bagh | Company Secretary & Compliance Officer
Mr. Shitul Shah | Additional Whole Time Director
Mr. Paresh Chawla | MD & Director

How many employees does ALPA.NS have?

Number of ALPA.NS employees currently stands at 318. ALPA.NS operates from 33/2 Pigdamber, Indore, None 453446, IN.

Link for ALPA.NS official website?

Official Website of ALPA.NS is: https://www.alpalabs.in

How do I contact ALPA.NS?

ALPA.NS could be contacted at phone #91 73 1429 4567 and can also be accessed through its website. ALPA.NS operates from 33/2 Pigdamber, Indore, None 453446, IN.

How many shares of ALPA.NS are traded daily?

The average number of ALPA.NS shares traded daily for last 3 months was 195.16K.

What is the market cap of ALPA.NS currently?

The market value of ALPA.NS currently stands at $2.14B with its latest stock price at $101.9